Investment
Features
FeesSafety
Academy
More
Pluang+

Securities fraud lawsuit filed against Fluence Energy over missed financial targets and production delays

Market News
29 Sep 2026
Newsfile Corp
View Source
Bearish
Securities fraud lawsuit filed against Fluence Energy over missed financial targets and production delays

Fluence Energy faces a securities fraud lawsuit alleging it misled investors about its ability to meet fiscal 2026 financial guidance due to unfinished and ineffective manufacturing facilities. The company disclosed delays pushing $400 million in project deliveries into fiscal 2027, leading to lowered revenue and earnings forecasts and a significant drop in share price. Investors who bought Fluence securities between November 2025 and September 2026 and suffered losses may be eligible to join the lawsuit. The deadline to seek lead plaintiff status is November 27, 2026, and investors are encouraged to contact Block & Leviton for more information or to participate.

Fluence Energy faces a securities fraud lawsuit. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Sep 30, 2026 03:11 WIB: Of 93 priced stocks, 45 rose and 48 fell. Notable movers include BAH at USD 70.24 with a -3.71% change and 100% buy order activity, RKLB at USD 69.75 with a -3.38% change and 66% sell order activity, and MTZ at USD 210.68 with a +3.23% change and 100% buy order activity.

More News

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron Technology is set to report record quarterly revenue of up to $51.33 billion, fueled by strong demand for high-bandwidth memory in the AI market. Earnings per share are expected to jump significantly to around $31.72, compared to $3.03 last ye...

Company Fundamentals
Bullish
32 minutes ago
Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma Technologies reported a smaller-than-expected loss with an EPS of -$0.08, beating analyst estimates of -$2.19, though its revenue of $48.55 million slightly missed expectations. Despite ongoing profitability challenges reflected in a negative...

Company Fundamentals
Bullish
2 hours ago
Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics has increased its full-year 2026 revenue guidance to $410-$420 million, reflecting nearly 60% growth driven by strong U.S. demand for its cancer therapy Amtagvi, which generated $91 million in Q2 sales. Analyst Joseph Pantgini...

Analyst Insights
Bullish
3 hours ago
uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure's stock fell sharply by 37% following a four-year update on its AMT-130 gene therapy for Huntington's disease, which showed reduced effectiveness from 80% at three years to 44% at four years, failing to reach statistical significance. Despite...

Market News
Bearish
3 hours ago
Grizzly Discoveries clarifies use of $2M private placement proceeds for mineral exploration and working capital

Grizzly Discoveries clarifies use of $2M private placement proceeds for mineral exploration and working capital

Grizzly Discoveries Inc. announced a non-brokered private placement aiming to raise up to $2 million. The proceeds will be used for general working capital and exploration of its mineral properties, with specific funds from certain units targeting cr...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App